Lumenis, an Israel-based medical laser company for ophthalmic and surgical applications, received FDA 510(k) clearance for the ResurFX, a fractional non-ablative laser module.
The ResurFX is part of Lumenis' M22 platform. It uses a 1565 nm fiber laser and CoolScan scanner which create a homogeneous pattern of coagulation columns.
More Articles on Ophthalmology:
UC Irvine to Open $39M Gavin Herbert Eye Institute
7 Statistics on Rewarding Aspects of Ophthalmology Practice
Saratoga Vitreo-Retina Ophthalmology Celebrates 6k Patient Milestone
The ResurFX is part of Lumenis' M22 platform. It uses a 1565 nm fiber laser and CoolScan scanner which create a homogeneous pattern of coagulation columns.
More Articles on Ophthalmology:
UC Irvine to Open $39M Gavin Herbert Eye Institute
7 Statistics on Rewarding Aspects of Ophthalmology Practice
Saratoga Vitreo-Retina Ophthalmology Celebrates 6k Patient Milestone